The application of nanoparticles in medical catalysis has emerged as a promising frontier in biomedical research, offering novel pathways for therapeutic interventions. This study investigates the catalytic properties of Palladium (Pd), Gold (Au), and Iron (Fe) nanoparticles, focusing on their potential to enhance medical treatments. Through a series of in vitro and in vivo experiments, we evaluate the efficiency, stability, and biocompatibility of these nanoparticles in various medical applications, including drug delivery, diagnostic imaging, and tissue engineering.

Palladium nanoparticles are highlighted for their exceptional catalytic efficiency and ability to facilitate hydrogenation reactions, making them suitable for targeted drug activation. Gold nanoparticles, renowned for their biocompatibility and ease of functionalization, demonstrate significant potential in photothermal therapy and as contrast agents in imaging techniques. Iron nanoparticles, with their magnetic properties, offer advantages in magnetic resonance imaging (MRI) and targeted drug delivery systems. The comparative analysis reveals that while Palladium nanoparticles excel in catalytic activity, Gold and Iron nanoparticles provide superior versatility and functionalization capabilities. The innovative use of Pd, Au, and Fe nanoparticles in medical catalysis not only enhances the efficacy of existing treatments but also opens new avenues for developing advanced therapeutic techniques.

Medical Catalysis, Palladium Nanoparticles, Gold Nanoparticles

G.A. Somorjai, Introduction to Surface Chemistry and Catalysis. 1st ed., Wiley, New York, 1994, p. 667.

M. Bowker, J. J. Crouch, A. F. Carley, P. R. Davies, D. J. Morgan, G. Lalev, S. Dimov,and D. T. Pham, Encapsulation of Aunanoparticles on a silicon wafer during thermal oxidation, Journal of Physical Chemistry C 117 (41), 2013, 21577-21582.

Davies, R. et.al, A facile route to model catalysts: the synthesis of Au@Pd core-shell nanoparticles on y-Fe2O3 (0001), Nanoscale 5, 2013, 9018-9022.

Kwangjae Cho, XuWang, Shuming Nie, Zhuo (Georgia) Chen, and Dong M. Shin, Therapeutic Nanoparticles for Drug Delivery in Cancer, American Association for Cancer,2008.

Bamroongwongdee, C. et al. , Fabrication of complex model oxide catalysts: Mo oxide supported on Fe3O4 (111), Faraday Discussions 162, 2013, 201-212,

Altass, H. et al. , Enhancing surface reactivity with a noble metal. Chemical Communications 49 (74), 2013, 8223-8225.

F. Zaera, Prog. Surf. Sci. 69 (2001) 1–98.

D.W. Goodman, Chem. Rev. 95 (1995) 523–536.

D.W. Goodman, Surf. Sci. 299/300 (1994) 837–848.

F. Besenbacher, I. Chorkendorff, B.S. Clausen, B. Hammer, A.M. Molenbroek, J.K. Nørskov, and I. Stensgaard, Science 279 (1998) 1913–1915.

J. Greeley, J.K. Norskov, and M. Mavrikakis, Annu. Rev. Phys. Chem. 53 (2002) 319–348

I.Chorkendorff and J.W. Niemantserdriet, Concepts of Modern Catalysis and Kinetics. Wiley-VCH, Weinheim, 2003.

K.W. Kolasinski, Surface Science: Foundations of Catalysis and Nanoscience, Wiley, West Sussex, 2002. 28. J.W. Niemantsverdriet, Spectroscopy in Catalysis. VCH, New York, 1993.

D.P. Woodruff and T.A. Delchar, Modern Techniques of Surface Science-Second Edition, Cambridge Solid State Science Series. Cambridge University Press, Cambridge, 1994.

A.K. Santra and D.W. Goodman, Size-dependent electronic, structural, and catalytic properties of metal clusters supported on ultrathin oxide films, in Catalysis and Electrocatalysis at Nanoparticle Surfaces, eds. A. Wieckowski, E.R. Savinova, and C.G. Vayenas, Marcel Dekker, New York, 2003, 281–309.